| Added by | mollevi |
|---|---|
| Group name | EquipeCG |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Department of Medical Oncology, Nimes University Hospital, Nimes, France. nadine.houede@chu-nimes.fr. INSERM U1194, Montpellier, France. nadine.houede@chu-nimes.fr. Department of Medical Oncology, Curie Institute, Paris, France. philippe.beuzeboc@curie.net. Biostatistics Unit, ICM - Montpellier Cancer Institute, Montpellier, France. sophie.gourgou@icm.unicancer.fr. Department of Medical Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. diego.tosi@icm.unicancer.fr. Department of Medical Oncology, Francois Baclesse Cancer Centre, Caen, France. l.moise@baclesse.fr. Department of Medical Oncology, Paoli Calmette Institute, Marseille, France. gravisg@ipc.unicancer.fr. Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France. r.delva@unimedia.fr. Department of Medical Oncology, Leon Berard Cancer Centre, Lyon, France. aude.flechon@lyon.unicancer.fr. Clinique Pasteur, Toulouse, France. i.latorzeff@clinique-pasteur.com. Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France. jean-marc.ferrero@nice.unicancer.fr. Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. stephane.oudard@egp.aphp.fr. Department of Medical Oncology, Lyon University Hospital, Lyon, France. sophie.tartas@chu-lyon.fr. Department of Medical Oncology, Eugene Marquis Cancer Centre, Rennes, France. b.laguerre@rennes.unicancer.fr. Department of Medical Oncology, Montpellier University Hospital, Montpellier, France. d-topart@chu-montpellier.fr. Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. g.roubaud@bordeaux.unicancer.fr. INSERM U1194, Montpellier, France. hanane.agherbi@inserm.fr. Department of Urology, Clinique Beausoleil, Montpellier, France. xavier.rebillard@wanadoo.fr. INSERM U1194, Montpellier, France. david.azria@montpellier.unicancer.fr. Department of Radiation Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. david.azria@montpellier.unicancer.fr. alt-title: BMC cancer accession-num: 25884302 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 10:05:58 |
| Date Modified | 2018/07/20 - 10:05:58 |
| Parent item | Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France |
Institut de Recherche en Cancérologie de
